Davis's Drug Guide
deucravacitinib
General
Pronunciation:
doo-krav-a-sye-ti-nib
Trade Name(s)
- Sotyktu
Ther. Class.
antipsoriatics
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Deucravacitinib." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110934/4/deucravacitinib.
Vallerand AHA, Sanoski CAC, Quiring CC. Deucravacitinib. Davis's Drug Guide. F.A. Davis Company; 2023. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110934/4/deucravacitinib. Accessed April 30, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Deucravacitinib. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110934/4/deucravacitinib
Vallerand AHA, Sanoski CAC, Quiring CC. Deucravacitinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 April 30]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110934/4/deucravacitinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - deucravacitinib
ID - 110934
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110934/4/deucravacitinib
PB - F.A. Davis Company
ET - 18
DB - Anesthesia Central
DP - Unbound Medicine
ER -
